Anika Therapeutics, Inc. Payments for Restructuring
Anika Therapeutics, Inc. (ANIK) reported Payments for Restructuring of $530.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-07-29
- Anika Therapeutics, Inc. payments for restructuring for the quarter ending 2026-06-30 was $384.00K.
- Anika Therapeutics, Inc. payments for restructuring for the quarter ending 2026-03-31 was $146.00K.
- Anika Therapeutics, Inc. payments for restructuring for the quarter ending 2014-09-30 was $3.30K, a 100.00% decline year-over-year.
- Anika Therapeutics, Inc. payments for restructuring for the quarter ending 2014-06-30 was $3.40K.
- Anika Therapeutics, Inc. payments for restructuring for fiscal 2013 was -$770.84K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2026-06-30 | $384.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $530.00K 10-Q · filed 2026-07-29 | ||
| 2026-03-31 | $146.00K 10-Q · filed 2026-04-30 | |||
| 2014-09-30 | $3.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $6.71K derived: sum of 2 quarters · filed 2014-11-06 | $11.55K 10-Q · filed 2014-11-06 | -$738.36B derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-06-30 | $3.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $8.25K 10-Q · filed 2014-08-04 | -$738.36B derived: sum of 3 quarters · filed 2014-08-04 | -$1.42M derived: sum of 4 quarters · filed 2014-08-04 |
| 2014-03-31 | $4.85K 10-Q · filed 2014-05-05 | -$738.36B derived: sum of 2 quarters · filed 2014-05-05 | -$1.43M derived: sum of 3 quarters · filed 2014-05-05 | |
| 2013-12-31 | -$738.36B derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$1.43M derived: sum of 2 quarters · filed 2014-03-13 | -$770.84K 10-K · filed 2014-03-13 | |
| 2013-09-30 | $738.36B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $738.36B 10-Q · filed 2013-11-05 | ||
| 2013-06-30 | $659.11K 10-Q · filed 2013-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |